A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: Con

Eur Urol Focus. 2023 Jul;9(4):559-560. doi: 10.1016/j.euf.2023.03.009. Epub 2023 Apr 1.

Abstract

Repeat transurethral resection (re-TUR) remains the standard procedure for high-grade T1 non-muscle-invasive bladder cancer. However, en block resection together with improved imaging modalities (photodynamic diagnosis) may reduce the risk of persistent disease and/or upstaging at re-TUR. Thus, re-TUR may be spared in selected patients with a complete initial resection with well-represented and tumor-free detrusor muscle in the specimen, with a significant impact on patients' quality of life and health care costs.

MeSH terms

  • Humans
  • Neoplasm Staging
  • Non-Muscle Invasive Bladder Neoplasms*
  • Quality of Life
  • Urinary Bladder / diagnostic imaging
  • Urinary Bladder / pathology
  • Urinary Bladder / surgery
  • Urinary Bladder Neoplasms* / pathology
  • Urinary Bladder Neoplasms* / surgery